Bassan I - Search Results

1

Establishment and characterization of the Cuvier's beaked whale (Ziphius cavirostris) myogenic cell line.

Peruffo A, Bassan I, Gonella A, Maccatrozzo L, Otero-Sabio C, Iannuzzi L, Perucatti A, Pistucci R, Giacomello M, Centelleghe C. Peruffo A, et al. Among authors: bassan i. Res Vet Sci. 2025 Jan;182:105471. doi: 10.1016/j.rvsc.2024.105471. Epub 2024 Nov 26. Res Vet Sci. 2025. PMID: 39608061 Free article.

2

Discovering the Protective Effects of Quercetin on Aflatoxin B1-Induced Toxicity in Bovine Foetal Hepatocyte-Derived Cells (BFH12).

Pauletto M, Giantin M, Tolosi R, Bassan I, Bardhi A, Barbarossa A, Montanucci L, Zaghini A, Dacasto M. Pauletto M, et al. Among authors: bassan i. Toxins (Basel). 2023 Sep 6;15(9):555. doi: 10.3390/toxins15090555. Toxins (Basel). 2023. PMID: 37755981 Free PMC article.

3

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.

Romero-Gómez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, Kaufman KD, Engel SS; MK-6024 P001 Study Group. Romero-Gómez M, et al. J Hepatol. 2023 Oct;79(4):888-897. doi: 10.1016/j.jhep.2023.05.013. Epub 2023 Jun 22. J Hepatol. 2023. PMID: 37355043 Free article. Clinical Trial.

4

Deepening the Whole Transcriptomics of Bovine Liver Cells Exposed to AFB1: A Spotlight on Toll-like Receptor 2.

Iori S, Pauletto M, Bassan I, Bonsembiante F, Gelain ME, Bardhi A, Barbarossa A, Zaghini A, Dacasto M, Giantin M. Iori S, et al. Among authors: bassan i. Toxins (Basel). 2022 Jul 20;14(7):504. doi: 10.3390/toxins14070504. Toxins (Basel). 2022. PMID: 35878242 Free PMC article.

5

Does Bentonite Cause Cytotoxic and Whole-Transcriptomic Adverse Effects in Enterocytes When Used to Reduce Aflatoxin B1 Exposure?

Mucignat G, Bassan I, Giantin M, Pauletto M, Bardhi A, Iori S, Lopparelli RM, Barbarossa A, Zaghini A, Novelli E, Dacasto M. Mucignat G, et al. Among authors: bassan i. Toxins (Basel). 2022 Jun 26;14(7):435. doi: 10.3390/toxins14070435. Toxins (Basel). 2022. PMID: 35878173 Free PMC article.

6

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.

Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group. Peyrin-Biroulet L, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798039 Free article. Clinical Trial.

7

Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.

Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group. Vermeire S, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798037 Clinical Trial.

8

Discovering the Protective Effects of Resveratrol on Aflatoxin B1-Induced Toxicity: A Whole Transcriptomic Study in a Bovine Hepatocyte Cell Line.

Pauletto M, Giantin M, Tolosi R, Bassan I, Barbarossa A, Zaghini A, Dacasto M. Pauletto M, et al. Among authors: bassan i. Antioxidants (Basel). 2021 Jul 29;10(8):1225. doi: 10.3390/antiox10081225. Antioxidants (Basel). 2021. PMID: 34439473 Free PMC article.

9

Curcumin Mitigates AFB1-Induced Hepatic Toxicity by Triggering Cattle Antioxidant and Anti-inflammatory Pathways: A Whole Transcriptomic In Vitro Study.

Pauletto M, Giantin M, Tolosi R, Bassan I, Barbarossa A, Zaghini A, Dacasto M. Pauletto M, et al. Among authors: bassan i. Antioxidants (Basel). 2020 Oct 29;9(11):1059. doi: 10.3390/antiox9111059. Antioxidants (Basel). 2020. PMID: 33137966 Free PMC article.

10

Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.

Melmed GY, Pandak WM, Casey K, Abraham B, Valentine J, Schwartz D, Awais D, Bassan I, Lichtiger S, Sands B, Hanauer S, Richards R, Oikonomou I, Parekh N, Targan S, Johnson K, Hariri R, Fischkoff S. Melmed GY, et al. Among authors: bassan i. Inflamm Bowel Dis. 2015 Aug;21(8):1809-16. doi: 10.1097/MIB.0000000000000441. Inflamm Bowel Dis. 2015. PMID: 25985246 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters